A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system to go after cancer cells.
Copyright 2026 NPR
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C.
